Bionano Genomics, Inc. (BMV:BNGO)

Market Cap	201.10M -46.9%
Revenue (ttm)	526.79M -13.8%
Net Income	-707.77M
EPS	-215.57
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	45
Average Volume	121
Open	20.10
Previous Close	23.00
Day's Range	19.99 - 20.10
52-Week Range	19.99 - 115.00
Beta	n/a
RSI	26.79
Earnings Date	Mar 12, 2026

About Bionano Genomics

Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It also provides Saphyr and Stratys systems, which are sample-to-result solutions for structural variation analysis by optical genome mapping for genome anal...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2003
• Employees: 100
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: BNGO

Financial Performance

In 2024, Bionano Genomics's revenue was $30.78 million, a decrease of -14.79% compared to the previous year's $36.12 million. Losses were -$112.02 million, -51.82% less than in 2023.

Financial numbers in USD